| Literature DB >> 22455445 |
Mariluz Arainga1, Eri Takeda, Yoko Aida.
Abstract
BACKGROUND: Bovine leukemia virus (BLV) is associated with enzootic bovine leukosis and is closely related to human T-cell leukemia virus type I. The Tax protein of BLV is a transcriptional activator of viral replication and a key contributor to oncogenic potential. We previously identified interesting mutant forms of Tax with elevated (TaxD247G) or reduced (TaxS240P) transactivation effects on BLV replication and propagation. However, the effects of these mutations on functions other than transcriptional activation are unknown. In this study, to identify genes that play a role in the cascade of signal events regulated by wild-type and mutant Tax proteins, we used a large-scale host cell gene-profiling approach.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22455445 PMCID: PMC3441221 DOI: 10.1186/1471-2164-13-121
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Figure 1Expression, localization, and transactivation of wild-type and mutant Tax proteins in HeLa cells. HeLa cells were transfected with pCAGGS encoding Flag-tagged Tax proteins (TaxWT, TaxS240P, or TaxD247G) or the control pCAGGS without (A and B) or with the reporter plasmid pGV-BLTR and the reference plasmid pRL-SV40 ( C). Thereafter, 24 h after transfection, cells were subjected to western blotting ( A), confocal laser-scanning analysis ( B), and the firefly luciferase assay ( C). ( A) Western blotting was performed using an anti-Flag M2 MAb and anti-actin antibody as a control. ( B) For immunofluorescence, cells were fixed, permeabilized, and immunostained with anti-Flag M2 MAb followed by the Alexa-488-conjugated anti-mouse antibody (green). ( C) For the transactivation assay, cells were recovered and lysed, and the activities of firefly and Renilla luciferase were measured. For each sample, the firefly luciferase activity (pGV-BLTR) was normalized by reference to Renilla luciferase activity (pRL-SV40). Average values from triplicate transfections with standard deviations (error bars) are shown (*p < 0.01).
Figure 2Differential expression of cellular genes after induction of wild-type and mutant Tax proteins in HeLa cells. Total RNA from HeLa cells transfected with pCAGGS encoding Tax proteins (TaxWT, TaxS240P, or TaxD247G) or the control pCAGGS was used for the microarray analysis. (A) Heat map of hierarchical gene clustering. The microarray data was analyzed using GeneSpring GX 11.0 software to obtain the hierarchical clustering. The columns correspond to gene profiles regulated by the different Tax proteins indicated above the map. Below the heat map is a color-coded scale bar for the relative expression levels of genes. ( B) Number of genes significantly up- or downregulated by wild-type and mutant Tax proteins. The genes shown in this figure passed 2 filtering criteria: (1) statistical significance (p < 0.05) and (ii) at least 2-fold changes in the expression of a cellular gene at least 1 time point.
Figure 3Ontology annotations of differentially expressed genes after the transfection of wild-type and mutant Tax proteins. Classification of up- or downregulated genes involved in biological functions with significant differential expression (fold change > 2.0 and p < 0.05). TaxWT, open column; TaxS240, shaded column; TaxD247G, black column.
Genes upregulated in the total RNA fraction in the presence of wild-type and mutant Tax proteins
| | | | | | |
| 1390 | cAMP responsive element modulator | CREM | 2.2 | 1.8 | 3.2 |
| 1958 | early growth response 1 | EGR1 | 1.9 | 2.0 | 1.7 |
| 22936 | elongation factor, RNA polymerase II, 2 | ELL2 | 2.2 | 2.2 | 2.2 |
| 2119 | ets variant 5 | ETV5 | 3.7 | 3.6 | 3.4 |
| 2353 | FBJ murine osteosarcoma viral oncogene homolog | FOS | 3.7 | 2.4 | 4.6 |
| 8061 | FOS-like antigen 1 | FOSL1 | 2.4 | 2.4 | 2.3 |
| 3280 | Hairy and enhancer of split 1 (Drosophila) | HES1 | 1.8 | 1.9 | 2.0 |
| 3725 | jun oncogene | JUN | 4.7 | 5.9 | 5.3 |
| 10365 | Kruppel-like factor 2 (lung) | KLF2 | 2.6 | 2.6 | 2.8 |
| 1316 | Kruppel-like factor 6 | KLF6 | 2.1 | 2.1 | 2.1 |
| 9935 | v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian) | MAFB | 2.6 | 1.9 | 3.8 |
| 23764 | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) | MAFF | 2.4 | 1.9 | 2.6 |
| 4929 | nuclear receptor subfamily 4, group A, member 2 | NR4A2 | 3.6 | 1.5 | 7.7 |
| 57157 | Putative homeodomain transcription factor 2 | PHTF2 | 1.9 | 1.9 | 2.0 |
| 6095 | RAR-related orphan receptor A | RORA | 10.3 | 2.0 | 10.6 |
| 7538 | zinc finger protein 36, C3H type, homolog (mouse) | ZFP36 | 2.8 | 2.6 | 2.6 |
| | | | | | |
| 287 | ankyrin 2, neuronal | ANK2 | 2.0 | 2.0 | 1.4 |
| 9518 | growth differentiation factor 15 | GDF15 | 5.0 | 4.9 | 5.6 |
| 2669 | GTP binding protein over expressed in skeletal muscle | GEM | 14.3 | 5.0 | 19.1 |
| 10681 | guanine nucleotide binding protein (G protein), beta 5 | GNB5 | 2.0 | 1.2 | 2.4 |
| 2786 | guanine nucleotide binding protein (G protein), gamma 4 | GNG4 | 1.8 | 2.0 | 1.6 |
| 26207 | phosphatidylinositol transfer protein, cytoplasmic 1 | PITPNC1 | 1.9 | 1.7 | 2.5 |
| 5329 | plasminogen activator, urokinase receptor | PLAUR | 2.0 | 1.7 | 1.9 |
| 5521 | protein phosphatase 2 (formerly 2A), regulatory subunit B, beta isoform | PPP2R2B | 1.3 | 1.0 | 2.1 |
| 5997 | regulator of G-protein signaling 2, 24 kDa | RGS2 | 2.4 | 1.1 | 2.4 |
| 6004 | regulator of G-protein signaling 16 | RGS16 | 2.0 | 2.0 | 2.0 |
| 6236 | Ras-related associated with diabetes | RRAD | 3.8 | 2.3 | 7.9 |
| 81848 | sprouty homolog 4 (Drosophila) | SPRY4 | 1.9 | 2.1 | 1.9 |
| | | | | | |
| 2921 | chemokine (C-X-C motif) ligand 3 | CXCL3 | 1.8 | 2.0 | 1.8 |
| 3269 | histamine receptor H1 | HRH1 | 2.5 | 1.7 | 1.8 |
| 7130 | tumor necrosis factor, alpha-induced protein 6 | TNFAIP6 | 20.5 | 1.3 | 36.6 |
| | | | | | |
| 183 | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) | AGT | 1.3 | 1.3 | 2.3 |
| 374 | amphiregulin | AREG | 2.0 | 2.1 | 2.3 |
| 694 | B-cell translocation gene 1, anti-proliferative | BTG1 | 3.3 | 1.1 | 3.0 |
| 6347 | chemokine (C-C motif) ligand 2 | CCL2 | 2.0 | 1.6 | 1.6 |
| 960 | CD44 molecule (Indian blood group) | CD44 | 2.1 | 2.0 | 2.3 |
| 3491 | cysteine-rich, angiogenic inducer, 61 | CYR61 | 4.8 | 2.0 | 7.5 |
| 2014 | epithelial membrane protein 3 | EMP3 | 1.8 | 1.2 | 3.1 |
| 3589 | interleukin 11 | IL11 | 3.6 | 1.7 | 5.4 |
| 83729 | inhibin, beta E | INHBE | 2.1 | 3.0 | 1.9 |
| 182 | jagged 1 | JAG1 | 2.1 | 1.8 | 2.3 |
| 3976 | leukemia inhibitory factor (cholinergic differentiation factor) | LIF | 2.2 | 2.2 | 2.2 |
| | | | | | |
| 56892 | chromosome 8 open reading frame 4 | C8orf4 | 1.2 | 1.2 | 2.3 |
| 8870 | immediate early response 3 | IER3 | 3.3 | 3.2 | 3.7 |
| 22822 | pleckstrin homology-like domain, family A, member 1 | PHLDA1 | 2.5 | 1.9 | 3.2 |
| 51330 | tumor necrosis factor receptor superfamily, member 12A | TNFRSF12A | 2.0 | 1.9 | 2.0 |
| 27242 | tumor necrosis factor receptor superfamily, member 21 | TNFRSF21 | 2.3 | 2.1 | 2.4 |
| | | | | | |
| 6695 | sparc/osteonectin, cwcv and kazal-like domains proteoglycan 1 | SPOCK1 | 2.0 | 1.7 | 2.1 |
| 6696 | secreted phosphoprotein 1 | SPP1 | 1.9 | 2.5 | 2.1 |
| | | | | | |
| 3039 | hemoglobin, alpha 1 | HBA1 | 2.4 | 2.5 | 2.4 |
| 4884 | neuronal pentraxin I | NPTX1 | 2.3 | 1.2 | 3.6 |
| 6507 | solute carrier family 1, member 3 | SLC1A3 | 1.8 | 2.0 | 1.8 |
| 6533 | solute carrier family 6, member 6 | SLC6A6 | 2.2 | 2.3 | 1.9 |
| 23657 | solute carrier family 7, member 11 | SLC7A11 | 2.3 | 2.4 | 1.8 |
| | | | | | |
| 384 | arginase, type II | ARG2 | 3.2 | 3.2 | 3.6 |
| 9945 | glutamine-fructose-6-phosphate transaminase 2 | GFPT2 | 2.0 | 2.0 | 1.9 |
| 9388 | Lipase, endothelial | LIPG | 1.9 | 1.4 | 2.1 |
| 7378 | uridine phosphorylase 1 | UPP1 | 2.1 | 1.8 | 2.0 |
| | | | | | |
| 9201 | doublecortin-like kinase 1 | DCLK1 | 2.1 | 2.0 | 2.1 |
| 1843 | dual specificity phosphatase 1 | DUSP1 | 3.6 | 2.4 | 4.7 |
| 51207 | dual specificity phosphatase 13 | DUSP13 | 2.2 | 1.9 | 2.2 |
| 1846 | dual specificity phosphatase 4 | DUSP4 | 2.9 | 3.0 | 2.9 |
| 1847 | dual specificity phosphatase 5 | DUSP5 | 2.4 | 2.4 | 2.8 |
| 1848 | dual specificity phosphatase 6 | DUSP6 | 2.4 | 2.8 | 2.7 |
| 5578 | protein kinase C, alpha | PRKCA | 2.1 | 1.9 | 1.8 |
| | | | | | |
| 3337 | DnaJ (Hsp40) homolog, subfamily B, member 1 | DNAJB1 | 2.7 | 3.1 | 2.5 |
| 3303 | heat shock 70 kDa protein 1A | HSPA1A | 2.9 | 4.2 | 2.8 |
| 3310 | heat shock 70 kDa protein 6 | HSPA6 | 6.4 | 15.4 | 5.3 |
| | | | | | |
| 202 | absent in melanoma 1 | AIM1 | 1.7 | 1.8 | 2.1 |
| 23237 | activity-regulated cytoskeleton-associated protein | ARC | 2.5 | 2.3 | 2.3 |
| 1475 | cystatin A (stefin A) | CSTA | 4.6 | 5.3 | 5.4 |
| 56603 | cytochrome P450, family 26, subfamily B, polypeptide 1 | CYP26B1 | 2.1 | 1.7 | 2.1 |
| 23052 | endonuclease domain containing 1 | ENDOD1 | 2.0 | 2.1 | 2.1 |
| 2201 | fibrillin 2 | FBN2 | 2.1 | 1.6 | 1.8 |
| 10324 | kelch repeat and BTB (POZ) domain containing 10 | KBTBD10 | 3.0 | 1.9 | 2.4 |
| 5270 | serpin peptidase inhibitor, clade E, member 2 | SERPINE2 | 2.3 | 2.3 | 2.4 |
| 4071 | transmembrane 4 L six family member 1 | TM4SF1 | 1.9 | 1.8 | 2.3 |
| 25907 | transmembrane protein 158 (gene/pseudogene) | TMEM158 | 2.1 | 2.4 | 2.5 |
| 7171 | tropomysin 4 | TPM4 | 2.5 | 1.5 | 3.5 |
| 7846 | tubulin, alpha 1a | TUBA1A | 1.9 | 2.1 | 1.8 |
Genes downregulated in the total RNA fraction in the presence of wild-type and mutant Tax proteins
| | | | | | |
| 23741 | EP300 interacting inhibitor of differentiation 1 | EID1 | 2.0 | 2.1 | 2.0 |
| 2625 | GATA binding protein 3 | GATA3 | 2.0 | 1.6 | 1.6 |
| 3398 | inhibitor of DNA binding 2, dominant negative helix-loop-helix protein | ID2 | 1.6 | 1.4 | 2.2 |
| 23658 | LSM5 homolog, U6 small nuclear RNA associated (S. cerevisiae) | LSM5 | 1.7 | 1.8 | 2.0 |
| 63931 | mitochondrial ribosomal protein S14 | MRPS14 | 1.9 | 2.4 | 2.2 |
| 5936 | RNA binding motif protein 4 | RBM4 | 1.7 | 2.4 | 2.1 |
| 6591 | snail homolog 2 (Drosophila) | SNAI2 | 1.9 | 2.2 | 1.7 |
| | | | | | |
| 23586 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 | DDX58 | 2.9 | 3.3 | 3.9 |
| 79132 | DEXH (Asp-Glu-X-His) box polypeptide 58 | DHX58 | 2.1 | 2.2 | 2.3 |
| 10561 | interferon-induced protein 44 | IFI44 | 2.1 | 2.7 | 2.8 |
| 64135 | interferon induced with helicase C domain 1 | IFIH1 | 2.0 | 2.2 | 2.3 |
| 3434 | interferon-induced protein with tetratricopeptide repeats 1 | IFIT1 | 5.2 | 5.6 | 6.0 |
| 3433 | interferon-induced protein with tetratricopeptide repeats 2 | IFIT2 | 3.1 | 3.7 | 4.2 |
| 3437 | interferon-induced protein with tetratricopeptide repeats 3 | IFIT3 | 5.4 | 5.5 | 5.5 |
| 9636 | ISG15 ubiquitin-like modifier | ISG15 | 2.2 | 2.6 | 2.1 |
| 8638 | 2'-5'-oligoadenylate synthetase-like | OASL | 8.8 | 8.8 | 10.3 |
| 445347 | TCR gamma alternate reading frame protein | TARP | 1.9 | 3.0 | 1.1 |
| 6967 | T cell receptor gamma constant 2 | TRGC2 | 2.1 | 3.4 | 1.2 |
| 56829 | zinc finger CCCH-type, antiviral 1 | ZC3HAV1 | 2.9 | 2.9 | 3.2 |
| | | | | | |
| 3641 | insulin-like 4 (placenta) | INSL4 | 2.4 | 2.7 | 2.5 |
| 5122 | proprotein convertase subtilisin/kexin type 1 | PCSK1 | 2.8 | 2.8 | 2.5 |
| 25780 | RAS guanyl releasing protein 3 (calcium and DAG-regulated) | RASGRP3 | 1.6 | 2.1 | 1.8 |
| | | | | | |
| 94239 | H2A histone family, member V | H2AFV | 1.9 | 2.0 | 1.9 |
| 8334 | histone cluster 1, H2ac | HIST1H2AC | 2.1 | 2.0 | 2.0 |
| 8329 | histone cluster 1, H2ag | HIST1H2AG | 1.6 | 2.2 | 1.7 |
| 8349 | histone cluster 2, H2be | HIST2H2BE | 1.7 | 2.2 | 1.6 |
| | | | | | |
| 2247 | fibroblast growth factor 2 (basic) | FGF2 | 3.4 | 3.5 | 3.7 |
| 10216 | proteoglycan 4 | PRG4 | 1.7 | 2.2 | 1.7 |
| 5920 | retinoic acid receptor responder (tazarotene induced) 3 | RARRES3 | 2.3 | 2.4 | 2.5 |
| | | | | | |
| 8743 | tumor necrosis factor (ligand) superfamily, member 10 | TNFSF10 | 2.5 | 2.9 | 2.6 |
| | | | | | |
| 10083 | Usher syndrome 1 C (autosomal recessive, severe) | USH1C | 2.0 | 2.0 | 1.7 |
| | | | | | |
| 57101 | anoctamin 2 | ANO2 | 1.9 | 2.1 | 2.0 |
| 6337 | sodium channel, nonvoltage-gated 1 alpha | SCNN1A | 2.4 | 2.1 | 2.4 |
| 6717 | sorcin | SRI | 2.3 | 2.3 | 2.6 |
| | | | | | |
| 51191 | hect domain and RLD 5 | HERC5 | 4.9 | 5.0 | 5.7 |
| 55008 | hect domain and RLD 6 | HERC6 | 2.2 | 2.5 | 2.2 |
| | | | | | |
| 83990 | BRCA1 interacting protein C-terminal helicase 1 | BRIP1 | 1.4 | 2.1 | 1.8 |
| 79940 | chromosome 6 open reading frame 155 | C6orf155 | 1.5 | 2.1 | 1.5 |
| 1601 | disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) | DAB2 | 2.2 | 2.3 | 2.2 |
| 55601 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 60 | DDX60 | 3.7 | 4.1 | 4.3 |
| 2335 | fibronectin 1 | FN1 | 2.0 | 2.5 | 1.8 |
| 23387 | SIK family kinase 3 | KIAA0999 | 1.2 | 1.2 | 2.2 |
| 54809 | sterile alpha motif domain containing 9 | SAMD9 | 1.8 | 2.0 | 2.4 |
| 6414 | selenoprotein P, plasma, 1 | SEPP1 | 2.1 | 2.1 | 2.2 |
| 8470 | sorbin and SH3 domain containing 2 | SORBS2 | 2.2 | 2.4 | 2.4 |
Genes involved in signaling pathways regulated by wild-type and mutant Tax proteins (p < 0.05)*
| Direct p53 effectors | DUSP1, DUSP5, GDF15, HSPA1A, JUN, LIF | DUSP1, DUSP5, GDF15, HSPA1A, JUN, LIF, SPP1 | |
| Validated transcriptional targets of AP1 family members Fra1 and Fra2 | FOS, FOSL1, GATA3, JUN, LIF, PLAUR | FOS, FOSL1, IL8, JUN, LIF | FOS, FOSL1, JUN, LIF |
| IL1-mediated signaling events | DUSP1, FOS, FOSL1, | DUSP1, FOS, FOSL1, IL8, JUN | DUSP1, FOS, FOSL1, JUN |
| BMP receptor signalling | DUSP1, FOS, FOSL1, | DUSP1, FOS, FOSL1, IL8, JUN | DUSP1, FOS, FOSL1, JUN |
| p38 MAPK signaling pathway | DUSP1, FOS, FOSL1, | DUSP1, FOS, FOSL1, IL8, JUN | DUSP1, FOS, FOSL1, JUN |
| Regulation of p38-alpha and p38-beta | DUSP1, FOS, FOSL1, | DUSP1, FOS, FOSL1, IL8, JUN | DUSP1, FOS, FOSL1, JUN |
| IL12-mediated signaling events | ETV5, FOS, | ETV5, FOS, IL12A, JUN | ETV5, FOS, JUN |
| Role of Calcineurin-dependent NFAT signaling in lymphocytes | FOS, FOSL1, | FOS, FOSL1, IL8, JUN | FOS, FOSL1, JUN |
| Calcineurin-regulated NFAT-dependent transcription in lymphocytes | FOS, FOSL1, | FOS, FOSL1, IL8, JUN | FOS, FOSL1, JUN |
| FOXM1 transcription factor network | ETV5, FOS, HSPA1A | ETV5, FOS, HSPA1A | ETV5, FOS, HSPA1A |
| xef;ve CD4+ T cells | FOS, FOSL1, JUN | FOS, FOSL1, JUN | FOS, FOSL1, JUN |
| CXCR4-mediated signaling events | FOS, FOSL1, JUN | FOS, FOSL1, JUN | FOS, FOSL1, JUN |
| Glucocorticoid receptor signaling | FOS, | FOS, IL8, JUN | |
| ATF-2 transcription factor network | DUSP1, DUSP5, JUN | DUSP1, DUSP5, IL8, JUN | DUSP1, DUSP5, HES1, JUN |
| JNK signaling in the CD4+ TCR pathway | FOSL1, JUN | FOS, FOSL1, JUN | FOS, FOSL1, JUN |
| Ras signaling in the CD4+ TCR pathway | FOS, FOSL1, JUN | FOS, FOSL1, JUN | FOS, FOSL1, JUN |
| xef;ve CD8+ T cells | FOS, FOSL1, JUN | FOS, FOSL1, JUN | FOS, FOSL1, JUN |
| Calcium signaling in the CD4+ TCR pathway | FOS, FOSL1, JUN | FOS, FOSL1, JUN | FOS, FOSL1, JUN |
| Regulation of Wnt-mediated beta catenin signaling and target gene transcription | CYR61, JUN | IL8, JUN, | CYR61, |
| IL2-mediated signaling events | FOS, JUN | FOS, JUN | FOS, JUN |
| ErbB2/ErbB3 signaling events | FOS JUN | FOS, JUN | FOS, JUN |
| BCR signaling pathway | FOS, JUN | FOS, JUN | FOS, JUN |
| IL12 signaling mediated by STAT4 | ETV5, JUN | ETV5, JUN | ETV5, JUN |
| PDGFR-alpha signaling pathway | FOS, JUN | FOS, JUN | FOS, JUN |
| Integrins in angiogenesis | CD44, | CD44, | CD44, |
| amb2 Integrin signalling | CYR61, PLAUR |
*Up- or downregulated genes are represented by regular or italic characters, respectively.
Figure 4Validation of differentially expressed genes at the RNA and protein levels in HeLa cells. Differential expression of up- ( A) or downregulated ( B) genes in HeLa cells transfected with pCAGGS encoding Flag-tagged Tax proteins (TaxWT, open column; TaxS240, shaded column; TaxD247G, black column) or the control pCAGGS (light column) was validated by real-time RT-PCR. The bars indicate the fold change expression of the genes regulated by Tax. Data were normalized to GAPDH mRNA expression. The results represent the mean of 2 samples from 1 experiment. (C) Protein expressions of Tax, Fos, Rora, Rrad, Gem, and Tnfaip6 were validated by western blotting. Actin was used as a control.
Figure 5Validation of differentially expressed genes at the RNA and protein levels in bovine 23CLN cells. 23CLN cells were transfected with pCAGGS encoding Flag-tagged Tax proteins (TaxWT, open column; TaxS240, shaded column; TaxD247G, black column) or the control pCAGGS (light column). Thereafter, 24 h after transfection, cells were subjected to confocal laser-scanning analysis to detect localization (A) and to real-time RT-PCR ( B and C) and western blotting ( D) to validate in bovine cells differential expression of cellular genes had altered after expression of wild-type and mutant Tax proteins in HeLa cells. The bars indicate the fold change expression of up- ( B) or downregulated ( C) genes regulated by Tax. Data were normalized to GAPDH mRNA expression. The results represent the mean of 2 samples from 1 experiment. ( D) The protein expression of Tax and Fos, Rrad, and Tnfaip6 was validated by western blotting. Actin was used as a control.